This Dutch Company is Upgrading ADCs for Immunotherapy – Labiotech.eu (blog)
Labiotech.eu (blog) |
This Dutch Company is Upgrading ADCs for Immunotherapy
Labiotech.eu (blog) T-Guard is CEO and co-founder Ypke van Oosterhout's life work. He told us about the technology that he has been developing since his graduate studies. It was during his post-MSc research that Ypke van Oosterhout 'discovered' T-Guard, a technology which … |
